Cocrystal Pharma, Inc.
Q1 2024 13F Holders
Symbol
COCP
CUSIP
19188J409
Type
Equity
Class
COM NEW
Num filings
20
Total reported value, excl. options
$1.18 M
Compare 2024 Q1 to
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2023 Q4
2023 Q3
2023 Q2
2023 Q1
2022 Q4
Manager
Report Date
Value ($000)
Shares
Option Type